Investor Alafi Capital Co Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Alafi Capital Co Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-05 13G/A CALC / CalciMedica, Inc. 1,295,678 1,583,153
2025-04-01 13G CALC / CalciMedica, Inc. 1,295,678
2019-09-30 13D/A ITCI / Intra-Cellular Therapies, Inc. 5,280,864 5,796,504
2017-10-30 13D/A ITCI / Intra-Cellular Therapies, Inc. 4,742,249 5,280,864
2015-03-24 13D/A ITCI / Intra-Cellular Therapies, Inc. 4,742,249
2013-09-09 13D ITCI / Intra-Cellular Therapies, Inc. 4,046,638